550 related articles for article (PubMed ID: 24991891)
41. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
J Neurooncol; 1996 Jan; 27(1):87-98. PubMed ID: 8699230
[TBL] [Abstract][Full Text] [Related]
42. Medulloblastoma in adults: treatment results and prognostic factors.
Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
[TBL] [Abstract][Full Text] [Related]
43. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
44. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
Allen JC; Donahue B; DaRosso R; Nirenberg A
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
[TBL] [Abstract][Full Text] [Related]
45. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
[TBL] [Abstract][Full Text] [Related]
46. Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas.
Abe M; Tokumaru S; Tabuchi K; Kida Y; Takagi M; Imamura J
Pediatr Neurosurg; 2006; 42(2):81-8. PubMed ID: 16465076
[TBL] [Abstract][Full Text] [Related]
47. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
Sung KW; Lim DH; Son MH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
[TBL] [Abstract][Full Text] [Related]
48. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B; Ozsahin M; Call J; Napieralska A; Kamer S; Villa S; Erpolat P; Negretti L; Lassen-Ramshad Y; Onal C; Akyurek S; Ugurluer G; Baumert BG; Servagi-Vernat S; Miller RC; Ozyar E; Sio TT
Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196
[TBL] [Abstract][Full Text] [Related]
49. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
50. [Pediatric medulloblastoma: Retrospective series of 52 patients].
Vigneron C; Antoni D; Coca A; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Niederst C; Jarnet D; Meyer P; Kehrli P; Noël G
Cancer Radiother; 2016 Apr; 20(2):104-8. PubMed ID: 26996790
[TBL] [Abstract][Full Text] [Related]
51. Effects of radiation treatment planning and patient fixation on the results of postoperative radiotherapy of childhood medulloblastoma.
Kocsis B; Székely G; Pap L; Németh G
Strahlenther Onkol; 2003 Dec; 179(12):854-9. PubMed ID: 14652675
[TBL] [Abstract][Full Text] [Related]
52. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
[TBL] [Abstract][Full Text] [Related]
53. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
[TBL] [Abstract][Full Text] [Related]
54. The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Vivekanandan S; Breene R; Ramanujachar R; Traunecker H; Pizer B; Gaze MN; Saran F; Thorp N; English M; Wheeler KA; Michalski A; Walker DA; Saunders D; Cowie F; Cameron A; Picton SV; Parashar D; Horan G; Williams MV
Pediatr Blood Cancer; 2015 Dec; 62(12):2132-9. PubMed ID: 26274622
[TBL] [Abstract][Full Text] [Related]
55. Treatment results for 149 medulloblastoma patients from one institution.
Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
[TBL] [Abstract][Full Text] [Related]
56. Medulloblastoma in young children.
Rutkowski S; Cohen B; Finlay J; Luksch R; Ridola V; Valteau-Couanet D; Hara J; Garre ML; Grill J
Pediatr Blood Cancer; 2010 Apr; 54(4):635-7. PubMed ID: 20146217
[TBL] [Abstract][Full Text] [Related]
57. Results of radiation therapy for unresected soft-tissue sarcomas.
Kepka L; DeLaney TF; Suit HD; Goldberg SI
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):852-9. PubMed ID: 16199316
[TBL] [Abstract][Full Text] [Related]
58. Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.
Whitton AC; Syndikus I; Tait DM; Bloom HJ
Strahlenther Onkol; 1995 Nov; 171(11):615-21. PubMed ID: 7502224
[TBL] [Abstract][Full Text] [Related]
59. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
[TBL] [Abstract][Full Text] [Related]
60. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]